|4Sep 20, 6:59 PM ET

Dervieux Thierry 4

4 · EXAGEN INC. · Filed Sep 20, 2019

Insider Transaction Report

Form 4
Period: 2019-09-18
Dervieux Thierry
Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-09-18+10,89110,891 total
    Exercise: $14.00Exp: 2029-09-17Common Stock (10,891 underlying)
Footnotes (1)
  • [F1]The option is exercisable as it vests. 25% of the shares subject to the option vest on September 18, 2020, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION